Donovan, K., Herrington, W., Haynes, R., Sardell, R., Baigent, C., Holmes, M., & Staplin, N. (2022). Fibroblast growth factor-23 and risk of cardiovascular diseases: A Mendelian randomization study. American Society of Nephrology.
Lua i Stíl Chicago (17ú heag.)Donovan, K., W. Herrington, R. Haynes, R. Sardell, C. Baigent, M. Holmes, agus N. Staplin. Fibroblast Growth Factor-23 and Risk of Cardiovascular Diseases: A Mendelian Randomization Study. American Society of Nephrology, 2022.
Lua MLA (9ú heag.)Donovan, K., et al. Fibroblast Growth Factor-23 and Risk of Cardiovascular Diseases: A Mendelian Randomization Study. American Society of Nephrology, 2022.
Rabhadh: Seans nach mbeach na luanna seo go hiomlán cruinn i ngach uile chás.